SpringWorks Therapeutics ... (SWTX)
NASDAQ: SWTX
· Real-Time Price · USD
46.47
0.20 (0.43%)
At close: May 23, 2025, 3:59 PM
46.48
0.03%
After-hours: May 23, 2025, 05:11 PM EDT
0.43% (1D)
Bid | 46.31 |
Market Cap | 3.5B |
Revenue (ttm) | 219.67M |
Net Income (ttm) | -253.93M |
EPS (ttm) | -3.41 |
PE Ratio (ttm) | -13.63 |
Forward PE | -55.77 |
Analyst | Hold |
Ask | 46.72 |
Volume | 5,673,013 |
Avg. Volume (20D) | 4,958,865.5 |
Open | 46.26 |
Previous Close | 46.27 |
Day's Range | 46.25 - 46.48 |
52-Week Range | 28.21 - 62.00 |
Beta | 0.77 |
About SWTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SWTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SWTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
SpringWorks Therapeutics Inc. is scheduled to release its earnings on May 27, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+9.03%
SpringWorks Therapeutics shares are trading higher...
Unlock content with
Pro Subscription
3 months ago
+7.54%
SpringWorks Therapeutics shares are trading higher following a Q4 revenue beat.

3 weeks ago · proactiveinvestors.co.uk
Merck KGaA swoops for US group SpringWorks in $3.4bn dealGermany's Merck KGaA has agreed to acquire US biotech firm SpringWorks Therapeutics for $3.9 billion in cash. The deal, announced on Monday, values SpringWorks at $47 a share and reflects an enterpris...